You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The 2010s saw major strides made through several large-scale initiatives aimed at mapping the human proteome and developing approaches for clinical work.
The funds will support the companies' efforts to develop tests for predicting NSCLC patients' response to immunotherapy.
In PNAS this week: Trypanosoma brucei transcripts, estimate of people at risk of inherited retinal disease, and more.
The test is designed to analyze the expression of 17 genes in order to differentiate mild and aggressive forms of Crohn's disease and ulcerative colitis.
Jennifer Doudna and Emmanuelle Charpentier are being awarded Israel's Wolf Prize in medicine for their CRISPR work, the Associated Press reports.
In Science this week: inefficiencies in negotiating data-use agreements can delay research, and more.
Researchers in the US and the United Arab Emirates found that RNA-seq in B-lymphoblastoid cell lines can help identify pathogenic variants that DNA testing missed.
New research suggests that a set of common variants on chromosome 22 may influence heart defects associated with a condition called 22q11.2 deletion syndrome.
The exclusive distribution deal expands the Finnish bioinformatics software company's footprint in the Middle East, Africa, and Asia.
A German shepherd called Nala has had her genome sequenced.
A coronavirus serology test garners Emergency Use Authorization from the US Food and Drug Administration, but the Los Angeles Times asks: how will tests like that be used?
Certain gene variants in conjunction with a healthy lifestyle may keep brains young, according to New Scientist.
In Science this week: increased CD8 T cell density and increased IFN-gamma response may indicate metastatic prostate cancer patients who will respond to immune checkpoint blockade therapy.